Featured Research

from universities, journals, and other organizations

Familial Breast Cancer Risk Continues Throughout a Woman's Life

Date:
May 15, 2008
Source:
Journal of the National Cancer Institute
Summary:
Women who have a sister diagnosed with breast cancer are at an increased risk of developing the disease throughout their lives. The increased risk is most pronounced in younger women, regardless of the age at which the first sister was diagnosed. Women who have a first degree relative affected by breast cancer are at increased risk for the disease, but it is unclear how a woman's risk varies with her current age and the age at which her relative was diagnosed.

Women who have a sister diagnosed with breast cancer are at an increased risk of developing the disease throughout their lives. The increased risk is most pronounced in younger women, regardless of the age at which the first sister was diagnosed.

Women who have a first degree relative affected by breast cancer are at increased risk for the disease, but it is unclear how a woman's risk varies with her current age and the age at which her relative was diagnosed.

To find out, Marie Reilly, Ph.D., and colleagues at the Karolinska Institute in Stockholm analyzed a national family database that is linked to the national cancer register. They compared the breast cancer incidence between 1958 and 2001 in 23,654 sisters of breast cancer patients and in 1,732,775 women who did not have a sister with breast cancer.

The familial risk was highest for young women, aged 20 to 39, with a 6.6-fold increase in the risk of breast cancer diagnosis, compared with similarly aged women who did not have a sister with breast cancer. The excess risk declined to approximately two-fold for women aged 50 and older. For the sisters of a breast cancer patient, the risk of diagnosis was similar regardless of whether she was approaching the age at which her sister had been diagnosed or had already passed it.

"Sisters of women diagnosed with breast cancer still have an increased risk of breast cancer 20 years after diagnosis of the sister, suggesting that women live with the burden of familial breast cancer for their lifetime," the authors write.


Story Source:

The above story is based on materials provided by Journal of the National Cancer Institute. Note: Materials may be edited for content and length.


Cite This Page:

Journal of the National Cancer Institute. "Familial Breast Cancer Risk Continues Throughout a Woman's Life." ScienceDaily. ScienceDaily, 15 May 2008. <www.sciencedaily.com/releases/2008/05/080513171505.htm>.
Journal of the National Cancer Institute. (2008, May 15). Familial Breast Cancer Risk Continues Throughout a Woman's Life. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2008/05/080513171505.htm
Journal of the National Cancer Institute. "Familial Breast Cancer Risk Continues Throughout a Woman's Life." ScienceDaily. www.sciencedaily.com/releases/2008/05/080513171505.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins